Healthcare

Healthcare

Natera’s Stronghold in Cancer Recurrence Tests Prompts Wood’s Ark to Expand Stake

Photo via Kris Tripplaar/Sipa USA/Newscom

Natera’s flagship product, Signatera is a personalized MRD blood test that detects cancer recurrence by identifying the unique DNA mutations.

2 min read

Photo via Stephane Lemouton/SIPA/Newscom

Artificial Intelligence

AI Drug Designer Isomorphic Details Lofty Plans for $2.1B in New Funding

Isomorphic previously raised $600 million in external funding last year, which was also led by NYC’s Thrive Capital.

1 min read
Photo via Michael Brochstein/ZUMAPRESS/Newscom

Healthcare

Hantavirus Trade Stalls as Officials Say Risk to Public Ranges from “Low” to “Very, Very Low”

Evercore ISI analysts said in a note they “see no meaningful revenue opportunity” for Moderna in hantaviruses.

2 min read
Photo via Michael Siluk/UCG/Universal Images Group/Newscom

Healthcare

Scoring 2 Million Prescriptions, Novo’s GLP-1 Pill Crushes Expectations

The pill era has ushered in a Wild-West-style land-grab for GLP-1 market share but the horizon seems to keep expanding.

2 min read

Healthcare

Cancer Treatments Propel Pfizer Sales Growth as Covid Revenue Dwindles

Photo via Richard B. Levine/Newscom

Operational revenue from Pfizer’s Covid vaccine Comirnaty and Paxlovid pill to treat the illness declined 59% and 63%, respectively.

2 min read

Artificial Intelligence

OpenAI Teams with Novo Nordisk to Speed Prescription Drug Development

Photo via Ritzau Scanpix/Sipa USA/Newscom

The move comes as OpenAI watches rival Anthropic make big enterprise splashes with its Claude Code and Mythos AI tools.

2 min read

Healthcare

Hims Teams up with Novo to Compete for Weight Loss Scripts

Photo via Michael Siluk/UCG/Universal Images Group/Newscom

The two struck a deal Monday for Hims to offer official versions of Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.